A new study drug for adults with symptomatic hypertrophic cardiomyopathy
Part of Heart & circulation clinical trials.
This study tests an experimental medication called Aom0304 for adults with symptomatic hypertrophic cardiomyopathy (a condition where the heart muscle is abnormally thick). The goal is to see if it helps reduce symptoms and improve heart function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have been diagnosed with hypertrophic cardiomyopathy (thickened heart muscle)
- You have symptoms like shortness of breath or chest pain
- You are on a stable dose of heart medications (like beta-blockers) for at least 4 weeks
- You have not had a heart muscle reduction procedure or taken certain newer heart drugs in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens, to learn more about how it affects them in real life. It may help doctors better understand and manage the condition.
This trial tests whether a personalized exercise program can safely improve fitness and daily activity for people with hypertrophic cardiomyopathy (a heart muscle condition). You would work with experts to build a routine that fits your needs and current health.
This trial uses a special CT scan to create a 3D model of your heart's blood flow. It aims to see if this model can help doctors better predict how well treatments work for people with a thick heart muscle that blocks blood flow.
This study looks at how hypertrophic cardiomyopathy (HCM) affects people in China in real-world settings. It may help doctors understand the condition better and improve care for patients like you.
This study tests a medication called aficamten in people with non-obstructive hypertrophic cardiomyopathy (a thickened heart muscle that affects how well the heart works). The goal is to see if it improves symptoms like fatigue and shortness of breath and helps you feel better in daily life.
This study tests whether mavacamten, a medication that may help the heart use energy better, can improve symptoms in people with obstructive hypertrophic cardiomyopathy. It aims to see if this drug helps with chest pain and shortness of breath, and improve overall heart function.
Hear when a new Hypertrophic Cardiomyopathy (HCM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.